- Court strikes down eight of Teva's patents on Copaxone
- Americans more likely than others to prefer generics, study finds
- Teva, Mylan launch Viagra generics in Europe
- Novartis to sell off blood transfusion diagnostics unit
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
PRINCETON, N.J. — Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.
The company, a subsidiary of Swiss drug maker Novartis, announced the launch of diltiazem hydrochloride extended-release capsules, a generic version of Forest Labs' Tiazac. Sandoz is launching the drug in the 120-mg, 180-mg, 240-mg, 300-mg, 360-mg and 420-mg strengths.
Various versions of the drug had sales of about $174 million in 2012, according to IMS Health.